Process development of TRI-999, a fatty-acid-modified HIV fusion inhibitory peptide

Zhang, H., Schneider, S. E., Bray, B., Friedrich, P., Tvermoes, N., Mader, C., Whight, S., Niemi, T., Silinski, P., Picking, T., Warren, M., & Wring, S. (2007). Process development of TRI-999, a fatty-acid-modified HIV fusion inhibitory peptide. Organic Process Research and Development, 12(1), 101 - 110.

Publications Info

To contact an RTI author, request a report, or for additional information about publications by our experts, send us your request.

Recent Publications

Article

"Show Me the Energy Costs"
Article

Effectiveness of interventions for the remediation of lead-contaminated soil to prevent or reduce lead exposure-A systematic review
Article

Variation in estimates of heat-related mortality reduction due to tree cover in US cities
Article

Promoting reproducibility and increased collaboration in electric sector capacity expansion models with community benchmarking and intercomparison efforts